SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-13-314875
Filing Date
2013-08-01
Accepted
2013-08-01 15:00:38
Documents
3
Effectiveness Date
2013-08-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A d574956ddefa14a.htm DEFA14A 23011
2 GRAPHIC g574956g37m51.jpg GRAPHIC 317903
3 GRAPHIC g574956g82x74.jpg GRAPHIC 348671
  Complete submission text file 0001193125-13-314875.txt   942902
Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 131002380
SIC: 2835 In Vitro & In Vivo Diagnostic Substances